Cancer News and Research

Latest Cancer News and Research

Idera presents IMO-3100 Phase 1 trial data in autoimmune diseases at Keystone Symposia

Idera Pharmaceuticals, Inc. today announced the presentation of data from its multiple-dose Phase 1 clinical trial of IMO-3100 in healthy subjects.

5 Apr 2011

Ectopic pregnancies on the rise

Ectopic - or tubal - pregnancies can be dangerous for mothers, leading to rupture of the fallopian tube and possible hemorrhage, and they appear to be on the rise, according to a new study.

5 Apr 2011

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry shows treatment with Risperdal Consta is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.

5 Apr 2011

Agilent launches SureCycler 8800 thermal cycler

Agilent Technologies, Inc. today introduced the Agilent SureCycler 8800, a full-featured thermal cycler that eliminates the need to choose between popular features of other major PCR instruments.

5 Apr 2011

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

New guidelines issued by the American Gastroenterological Association (AGA) support the use of radiofrequency ablation (RFA) to remove precancerous cells in patients with Barrett's esophagus, a condition most commonly caused by chronic acid reflux, or GERD. Barrett's esophagus is the leading cause of esophageal cancer and affects an estimated two million Americans.

5 Apr 2011

AACR President-elect to host press conference on cancer risk factors and genetics

As cancer continues to affect one in two men and one in three women, researchers are increasing their knowledge on the known risk factors for cancer both environmentally and genetically.

5 Apr 2011

Known cancer-linked gene involved in subset of advanced prostate tumors

Researchers at the University of Michigan Comprehensive Cancer Center have identified a genetic anomaly that may drive the aggressive spread of a rare subset of prostate cancers.

5 Apr 2011

South Asian Conference on Sanitation kicks off in Sri Lanka

The fourth South Asian Conference on Sanitation kicked off Monday in the Sri Lankan capital city of Colombo, to raise awareness about the "sanitation crisis in the region," Xinhua reports.

5 Apr 2011

Women with ovarian cancer having BRCA2 gene mutations are more likely to survive

Women with ovarian cancer who have the BRCA2 gene mutation are more likely to survive the malignancy than women with the BRCA1 mutation, or women without either mutation.

5 Apr 2011

Heavy beer drinkers with specific genetic variant at increased risk of non-cardia gastric cancer

Heavy beer drinkers who have a specific genetic variant in the cluster of three genes that metabolize alcohol are at significantly higher risk of developing non-cardia gastric cancer, according to research presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.

5 Apr 2011

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Eli Lilly and Company announced results today from two preclinical studies of molecules that target genetic mutations and disable specific signaling pathways that can lead to cancer. The studies evaluated two unique molecules – a JAK2 inhibitor and a Hedgehog inhibitor – with results presented during the American Association for Cancer Research (AACR) 102nd Annual Meeting in Orlando, Fla.

5 Apr 2011

Vitamin D can reduce estrogen receptor-positive breast cancer

In mice models of breast cancer, researchers at the Georgetown Lombardi Comprehensive Cancer Center, a part of Georgetown University Medical Center, found that vitamin D significantly reduced development of estrogen receptor-positive breast cancer both in lean and obese mice, but had no beneficial effect in estrogen receptor-negative cancer.

5 Apr 2011

AIDS people may face high risk of stomach and esophageal malignancies

Among people with AIDS, the risk of stomach and esophageal malignancies is higher than among the general population, according to study results presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.

5 Apr 2011

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

VisualSonics Inc., a leader in real time, in vivo, high-resolution micro-imaging systems and a wholly-owned subsidiary of SonoSite Inc., is demonstrating the recently announced Vevo LAZR Photoacoustics Imaging system at the American Association of Cancer Research's annual conference.

5 Apr 2011

Breast cancer updates

According to the latest research human breast milk holds the potential to assess a woman’s risk of developing breast cancer.

5 Apr 2011

Stand Up to Cancer awards UNC Lineberger scientist with 13 Innovative Research Grants

Angelique Whitehurst, PhD, assistant professor of pharmacology and a member of UNC Lineberger Comprehensive Cancer Center, has been awarded one of 13 Innovative Research Grants from Stand Up to Cancer, the scientific partner of the American Association of Cancer Research.

5 Apr 2011

Olivia’s cancer center receives $45 million for completion

Victorian Premier Ted Baillieu has finally sanctioned funds to complete the Olivia Newton-John Cancer and Wellness Centre. The Premier has committed almost $45 million to fit out the Austin Hospital project that was incomplete.

5 Apr 2011

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

ExonHit Therapeutics today announced the publication of Phase IIa results for EHT 0202, its lead candidate for the treatment of Alzheimer's disease, in the journal Current Alzheimer Research.

5 Apr 2011

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Caliper Life Sciences, Inc., a leading provider of tools and services for drug discovery, life sciences research and molecular diagnostics, today announced the launch of XenoLight RediJect COX-2 Probe, a novel fluorescent imaging agent for pre-clinical research that specifically detects the cyclooxygenase-2 biomarker noninvasively in live animal models as well as in ex vivo tissue analysis applications.

5 Apr 2011

Morphotek acquires tumor targeting assets from TMI

Morphotek, Inc., a subsidiary of Eisai Inc., announced today that it has acquired certain assets relating to a proprietary tumor targeting platform from TransMolecular, Inc. for an undisclosed upfront payment and future development milestones.

4 Apr 2011

Cancer News and Research

Latest Cancer News and Research

Idera presents IMO-3100 Phase 1 trial data in autoimmune diseases at Keystone Symposia

Ectopic pregnancies on the rise

Risperdal Consta can reduce risk of hospitalisation in patients with schizophrenia

Agilent launches SureCycler 8800 thermal cycler

AGA guidelines recommend RFA for removal of precancerous cells in patients with Barrett's esophagus

AACR President-elect to host press conference on cancer risk factors and genetics

Known cancer-linked gene involved in subset of advanced prostate tumors

South Asian Conference on Sanitation kicks off in Sri Lanka

Women with ovarian cancer having BRCA2 gene mutations are more likely to survive

Heavy beer drinkers with specific genetic variant at increased risk of non-cardia gastric cancer

Lilly presents results of JAK2, Hedgehog inhibitor preclinical cancer studies at 102nd AACR

Vitamin D can reduce estrogen receptor-positive breast cancer

AIDS people may face high risk of stomach and esophageal malignancies

VisualSonics demonstrates Vevo LAZR imaging system at AACR conference

Breast cancer updates

Stand Up to Cancer awards UNC Lineberger scientist with 13 Innovative Research Grants

Olivia’s cancer center receives $45 million for completion

Current Alzheimer Research publishes ExonHit's EHT 0202 Phase IIa results

Caliper introduces novel fluorescent imaging agent for pre-clinical research

Morphotek acquires tumor targeting assets from TMI

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in